Neuroimaging biomarkers are now routinely incorporated into AD clinical trials and are increasingly used in clinical practice. This paper broadly describes the development and use of these biomarkers as they relate to AD.
[button]Download[/button]
Neuroimaging biomarkers are now routinely incorporated into AD clinical trials and are increasingly used in clinical practice. This paper broadly describes the development and use of these biomarkers as they relate to AD.
[button]Download[/button]
Headquarters:
727 Madison Ave, Suite 29, Covington, Kentucky 41011
5060 Shoreham Place,
Ste 240, San Diego, CA 92122